Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 VaccineAccesswire • 06/13/24
Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/10/24
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial FindsForbes • 06/10/24
Moderna's combo COVID and flu vaccine works better than stand-alone shots on the market, study findsMarket Watch • 06/10/24
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSKInvestors Business Daily • 06/10/24
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trialCNBC • 06/10/24
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19Accesswire • 06/10/24
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?Investors Business Daily • 06/07/24
Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)Seeking Alpha • 06/07/24